Active ingredient
Doxepin
206 finished FDA listings contain Doxepin as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- DOXEPIN HYDROCHLORIDE
- Dosage forms
- Capsule, Cream, Solution, Tablet, Tablet, Film Coated
- Routes
- Oral, Topical
- Manufacturers / labelers
- 52
- Strengths listed
- 10 mg/1 · 10 mg/ml · 100 mg/1 · 150 mg/1 · 25 mg/1 · 3 mg/1 · 50 mg/1 · 50 mg/g · 6 mg/1 · 75 mg/1
- Brand names in FDA listings
- Doxepin, Doxepin Hydrochloride, Prudoxin, Silenor, Zonalon
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 3638
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 070791 | MYLAN PHARMS INC | 1986-05-13 | 18 |
| NDA 020126 | MYLAN | 1994-04-01 | 3 |
| ANDA 074721 | LANNETT CO INC | 1998-12-29 | 1 |
| NDA 022036 | CURRAX | 2010-03-17 | 4 |
| ANDA 201951 | ACTAVIS ELIZABETH | 2013-07-26 | 2 |
| ANDA 202337 | RK PHARMA | 2016-01-20 | 6 |
| ANDA 207482 | AMNEAL PHARMS CO | 2017-06-28 | 12 |
| ANDA 211603 | AUROBINDO PHARMA LTD | 2019-03-27 | 10 |
| ANDA 212624 | AJANTA PHARMA LTD | 2019-09-13 | 15 |
| ANDA 213063 | TARO | 2020-07-01 | 4 |
| ANDA 202510 | STRIDES PHARMA INTL | 2020-07-24 | 6 |
| ANDA 213474 | AIPING PHARM INC | 2020-07-28 | 15 |
| ANDA 210268 | CHARTWELL RX | 2020-09-04 | 5 |
| ANDA 210675 | EPIC PHARMA LLC | 2020-10-16 | 10 |
| ANDA 211618 | VELZEN PHARMA PVT | 2021-03-01 | 2 |
| ANDA 211619 | LEADING | 2021-03-09 | 5 |
| ANDA 214908 | APPCO | 2021-04-01 | 10 |
| ANDA 215076 | ALEMBIC | 2021-04-21 | 18 |
| ANDA 215710 | MANKIND PHARMA | 2022-02-09 | 18 |
| ANDA 215113 | MSN | 2022-06-24 | 16 |
| ANDA 215408 | TEVA PHARMS | 2023-02-17 | 1 |
| ANDA 214823 | MSN | 2023-04-03 | 5 |
| ANDA 202761 | ZYDUS LIFESCIENCES | 2023-08-16 | 4 |
| ANDA 212357 | AMNEAL | 2023-08-16 | 1 |
| ANDA 217975 | UNIQUE | 2023-08-21 | 5 |
| ANDA 218564 | AJANTA PHARMA LTD | 2024-07-01 | 2 |
| ANDA 216041 | AUROBINDO PHARMA LTD | 2024-07-25 | 4 |
| ANDA 219058 | TARO | 2025-08-06 | 4 |
Official labeling on DailyMed
- DOXEPIN HYDROCHLORIDE TABLET [REMEDYREPACK INC.] · version 3 · 2026-09-07
- DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.] · version 4 · 2026-09-07
- DOXEPIN (DOXEPIN HYDROCHLORIDE) TABLET [REMEDYREPACK INC.] · version 2 · 2026-09-07
- DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.] · version 3 · 2026-09-02
- DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.] · version 3 · 2026-09-02
- DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.] · version 3 · 2026-09-02
- DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.] · version 3 · 2026-09-02
- DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.] · version 3 · 2026-08-31
- DOXEPIN HYDROCHLORIDE CAPSULE [REMEDYREPACK INC.] · version 1 · 2026-08-25
- DOXEPIN HYDROCHLORIDE TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.] · version 1 · 2026-08-03
- DOXEPIN TABLET [NORTHSTAR RX LLC] · version 1 · 2026-08-03
- DOXEPIN HYDROCHLORIDE TABLET [NOVADOZ PHARMACEUTICALS LLC] · version 3 · 2026-07-29
Showing the 12 most recent of 101 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.